Skip to main content
Caplight Logo









Fizimed

Fizimed

Private
StrasbourgHealthcare & Life Scienceshttps://emy.fizimed.com/en-us

Last Round

Series A

Mar 13, 2025

Total Funding Raised

$5.06M

Momentum

Top 1%

of companies Caplight tracks

Company Overview

Fizimed operates in Healthcare & Life Sciences and is based in Strasbourg. Its latest recorded funding round was a Series A round in March 2025.

Fizimed is a health technology company that develops and markets connected medical devices for women's health, including pelvic floor trainers and breast pumps.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT, D2C Brands, Patient Engagement

Business Model

B2C

Customer Profile

Hardware Sales

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Fizimed Comparables

Compare Fizimed with similar companies based on industry and business-model similarity.

Fizimed comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Perifit
89%
Minna Life
81%
Bloom
78%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Fizimed Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AMar 13, 2025
VC RoundOct 10, 2019
SeedJan 1, 2018
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Allan MABILAIS

CTO - Co-founder

Founding Team

Julien Guay

CPO & co-founder

Founding Team

Emeline HAHN

CEO And co-founder

Founding Team

For institutional investors. Book with your work email.

Fizimed Investors

Notable investors and investment history

Fizimed investors
InvestorRounds
UI InvestissementSeries A
Capital Grand EstSeed, Series A, VC Round
BpifranceSeed, VC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 2, 2026

    Open roles increased to 19, 6x the trailing average.

  • May 19, 2026

    Monthly visitors increased 32% MoM.

Book a demo to see all signals

For institutional investors. Book with your work email.

Fizimed Filings

Explore SEC and related filing metadata, where available.

Fizimed filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Fizimed's valuation, stock price, and market status.

Is Fizimed a public or private company?

Fizimed is a private company.

What is the current stock price of Fizimed?

Fizimed is a private company, so its shares have no public market price. Caplight tracks Fizimed's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Fizimed worth (valuation)?

Valuation information for Fizimed is not publicly available.

Can I buy Fizimed stock?

Fizimed shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Fizimed's last funding round?

Fizimed's most recent funding round was Series A on March 13, 2025.

Who are the main investors in Fizimed?

Key investors in Fizimed include UI Investissement, Capital Grand Est, Bpifrance.

Will Fizimed IPO soon?

No public IPO plans have been announced for Fizimed.

How can I track Fizimed secondary market activity?

Caplight tracks bids, offers, and trades in Fizimed's shares on secondary markets.

Firmographic Details

HeadquartersStrasbourg
Employee Range20
Year Founded2017
Last FundingMar 13, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?